Login / Signup
RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials.
Khashayar Dashtipour
Roongroj Bhidayasiri
Jack J Chen
Bahman Jabbari
Mark Lew
Diego Torres-Russotto
Published in:
Journal of clinical movement disorders (2017)
BoNT-B significantly reduces sialorrhea at doses between 1500 and 4000 units. The relatively mild dose-dependent adverse events suggest both direct and remote toxin effects.
Keyphrases
</>
systematic review
clinical trial
meta analyses
escherichia coli
randomized controlled trial
phase iii
placebo controlled